Capillary Technologies India Ltd (CAPILLARY) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Capillary Technologies India Ltd on NSE and BSE, with an AI summary of each filing.
Allotment of Equity Shares under the Capillary Employees Stock Option Scheme - 2021.
Others (Uncategorized) · 04 Nov 2026, 6:14 pm
Capillary Technologies Allots 94,553 Equity Shares Under ESOP Plan 2021 The Nomination and Remuneration Committee of Capillary Technologies India Limited approved the allotment of 94,553 fully paid-up equity shares of face value ₹2 each on 4th Nov'26, pursuant to the exercise of vested options under the ESOP Plan 2021. The options were exercised at ₹2 per share with nil premium. Consequently, the company's total issued shares increased to 79,683,284, expanding its issued equity share capital to ₹15,93,66,568. The newly allotted shares rank pari passu with existing equity shares.
Monitoring agency report for the quarter ended September 30, 2026
Others (Uncategorized) · 03 Nov 2026, 4:06 pm
Capillary Technologies Issues Q2 FY27 Monitoring Agency Report on IPO Proceeds CRISIL Ratings released the Monitoring Agency Report for Capillary Technologies India Limited for the quarter ended 30th Sep'26, confirming zero deviations in IPO proceeds utilization. Out of total net proceeds of Rs 3,229.08 million (gross proceeds of Rs 3,450.00 million), the company has utilized Rs 1,470.54 million cumulatively, including Rs 273.62 million during the quarter. Deployments spanned AWS cloud infrastructure (Rs 157.38 million), R&D product development (Rs 105.32 million), and IT systems (Rs 10.92 million). Unutilized funds of Rs 1,791.16 million remain invested primarily in fixed deposits.
AUDIO RECORDING OF THE EARNINGS CONFERENCE CALL WITH ANALYST/INVESTORS HELD ON NOVEMBER 02, 2026.
Audio / Video · 03 Nov 2026, 12:49 am
Capillary Technologies Releases Audio Recording of Investor Earnings Call Capillary Technologies India Limited has made the audio recording of its earnings conference call with analysts and investors held on 2nd Nov'26 publicly available. In accordance with Regulation 30 of SEBI LODR Regulations, 2015, the recording has been uploaded to the company's official website under its investor relations section at https://www.capillarytech.com/investors/.
Change in the Internal Auditor of the Company
Change in Management · 02 Nov 2026, 6:08 pm
Capillary Technologies Appoints Deloitte Touche Tohmatsu as Internal Auditor Capillary Technologies India Limited's Board approved the appointment of Deloitte Touche Tohmatsu India LLP as Internal Auditor, replacing Protiviti India Member Private Limited effective 2nd Nov'26. Recommended by the Audit Committee, the transition aims to address the growing scale, complexity, and international operations across overseas subsidiaries while strengthening internal controls, risk management, and governance frameworks via Deloitte's global network and specialized audit expertise.
Press Release on Q2 Financial Results
Press Release · 02 Nov 2026, 6:04 pm
Capillary Technologies Reports Strong Q2 FY27 Results Driven by Revenue and EBITDA Expansion Capillary Technologies reported a 51% YoY rise in Q2 FY27 operating revenue to ₹2,713.5 Mn (+43% YoY CC, +6% QoQ), with H1 FY27 revenue growing 47% YoY to ₹5,280.0 Mn. Q2 FY27 Adjusted EBITDA surged 103% YoY to ₹448.6 Mn (+2% QoQ), while PAT rose to ₹219.2 Mn from ₹2.9 Mn in Q2 FY26. Growth was driven by existing customer expansion, strong net revenue retention, new ACV wins (+79% YoY on TTM basis), and the SessionM acquisition, which achieved breakeven.
Investor Presentation
Investor Presentation · 02 Nov 2026, 5:57 pm
Capillary Technologies Reports Strong Q2 FY27 With 51% YoY Revenue Growth Capillary Technologies delivered robust Q2 FY27 revenue of ₹2,713.5 Mn, up 51% YoY (6% QoQ), while Adj. EBITDA doubled to ₹448.6 Mn with a 17% margin. H1 FY27 revenue rose 47% YoY to ₹5,280.0 Mn, and PAT reached ₹123.7 Mn despite a ₹333.9 Mn cyber fraud provision in Q1 FY27. ARR expanded 51% YoY to ₹10,854 Mn, supported by 116% organic NRR and 55% YoY growth in subscription revenue. Full-year FY27 guidance remains on track at ₹10,650 Mn revenue and ₹1,720 Mn Adj. EBITDA.
Capillary Technologies India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 02 Nov 2026, 5:47 pm
Completion of closure of China operations and cessation of Capillary Technologies (Shanghai) Co, Ltd
Change in Management · 02 Nov 2026, 5:43 pm
Capillary Technologies Completes Voluntary Deregistration of China Step-Down Subsidiary Capillary Technologies India Limited has completed the voluntary deregistration and closure of its non-operative, wholly-owned step-down subsidiary, Capillary Technologies (Shanghai) Co., Ltd., China. The entity was not carrying on any business operations, reporting nil revenue and a net worth of 0.50 million for the fiscal year ended 31st Mar'26. Consequently, Capillary Shanghai has ceased to be a subsidiary. The closure is non-material and carries no financial or operational impact on the parent company or its group.
Financial Results for the quarter and half year ended 30-09-2026
Financial Result · 02 Nov 2026, 5:36 pm
Capillary Technologies Reports Strong Q2 FY27 Results; Appoints Deloitte as Internal Auditor Capillary Technologies India approved un-audited financial results for the quarter ended 30th Sep'26. Consolidated revenue from operations surged 51.3% YoY to ₹2,713.55 million, with QoQ growth of 5.7%. Net profit reached ₹219.16 million versus ₹2.88 million in the corresponding prior-year quarter, rebounding from a net loss of ₹95.52 million in Q1 FY27. For H1 FY27, consolidated revenue rose 47.0% YoY to ₹5,279.99 million, while PAT jumped to ₹123.64 million from ₹10.33 million. Separately, Deloitte Touche Tohmatsu India LLP was appointed internal auditor, replacing Protiviti India.
Outcome Of Board Meeting- Q2 Financial Results
Outcome · 02 Nov 2026, 5:27 pm
Capillary Technologies India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 2,714 (+51.3% YoY | +5.7% QoQ) ■ EBITDA: 395 (+111.7% YoY | -2.0% QoQ) ■ EBITDA Margin (%): 14.5 (+415 bps YoY | -115 bps QoQ) ■ PAT: 219 (+7509.7% YoY | Loss to Profit QoQ) ■ EPS (INR): 2.73 (+6725.0% YoY | Loss to Profit QoQ)
Capillary Technologies India Limited has updated the Exchange about the Summary of Final Forensic Audit Report.
Others (Uncategorized) · 01 Nov 2026, 12:30 am
KPMG Forensic Audit Confirms EUR 3.04 Mn Impersonation Fraud at Capillary Subsidiary Capillary Technologies received the final forensic audit report from KPMG regarding a payment-diversion fraud at step-down subsidiary Session M Czech Republic s.r.o. Between 26th Jun'26 and 2nd Jul'26, four disputed foreign payments totaling EUR 3,041,169.90 were executed to entities in Hong Kong and Singapore. The investigation established that external fraudsters impersonated executives and legal counsel using lookalike domains and off-channel communications. KPMG found no corporate technical compromise, malware, mailbox breaches, or employee wrongdoing. The company has strengthened payment controls and is pursuing legal recovery remedies.
Capillary Technologies India Limited has informed the Exchange about the final forensic audit report.
Others (Uncategorized) · 01 Nov 2026, 12:22 am
Capillary Technologies Receives KPMG Forensic Audit Report on Payment Diversion Fraud Capillary Technologies received KPMG’s final forensic audit report regarding EUR 3.04m in disputed payments executed between 26th Jun'26 and 2nd Jul'26 at step-down subsidiary Session M Czech Republic s.r.o. The investigation concluded the incident was a payment-diversion fraud driven by executive and legal impersonation, lookalike domains, and social engineering rather than technical endpoint, malware, or mailbox compromise. Three transfers went to HSBC Hong Kong and one to UOB Singapore. Deepfake allegations remain unverified, and onward fund tracing requires separate action.
Press Release - Capillary Strengthens US Leadership, Names Bill Swift as President, Americas.
Press Release · 29 Oct 2026, 7:26 pm
Capillary Technologies Appoints Bill Swift as President of Americas Capillary Technologies appointed Bill Swift as President, Americas, on 29th Oct'26 to accelerate growth across key verticals, including retail, hospitality, travel, and airlines. Swift, who previously served as CEO of Brierley+Partners and later as Chief Integration Officer at Capillary following its Apr'23 acquisition, brings nearly 30 years of loyalty industry expertise. In his new role, Swift will oversee regional business operations, sales, client delivery, and strategic execution to expand the company's AI-powered customer engagement footprint across the Americas.
To consider and approve the unaudited Standalone and Consolidated Financial Results for the period ended September 30, 2026
Intimation · 02 Nov 2026, 5:30 am
Intimation of schedule - Q2 & H1 FY 2026-27 Earnings Conference Call.
Intimation · 02 Nov 2026, 4:00 pm
Capillary Technologies Schedules Q2 and H1 FY27 Earnings Call Capillary Technologies India Limited will host its earnings conference call for analysts and investors on 2nd Nov'26 at 04:00 PM IST. The call follows the announcement of financial results for the quarter and half-year ended 30th Sep'26. Registration details have been made available via the company's investor portal.
Capillary Technologies India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Board Meeting ....
Intimation · 02 Nov 2026, 5:30 am
Capillary Technologies Schedules Board Meeting for Q2 FY27 Results Capillary Technologies India Limited announced that its Board of Directors will meet on 2nd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The trading window for dealing in company securities, closed since 1st Oct'26, will re-open 48 hours after the declaration of the financial results.
Capillary Technologies India Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 02 Nov 2026, 5:30 am
Intimation w.r.t. Appointment of Senior Management Personnel of the Company
Change in Management · 23 Oct 2026, 12:17 am
Capillary Technologies Appoints William Swift as President – Americas Region Capillary Technologies India Limited announced that its Board of Directors approved the appointment of Mr. William Swift as President – Americas Region, designating him as Senior Management Personnel effective 22nd Oct'26. Swift joined the company in Apr'23 following the acquisition of Brierley, where he previously served as CTO and CEO. In his new role, he will oversee operations, client engagement, strategic partnerships, and business development across the United States, Canada, Mexico, Central America, and South America.
Intimation of Schedule of Analyst/Institutional Investor Meet.
Intimation · 30 Sept 2026, 11:24 pm
Capillary Technologies Schedules Analyst and Institutional Investor Meetings for October 2026 Capillary Technologies India Limited has scheduled one-on-one institutional investor interactions under SEBI LODR Regulation 30. The company will conduct a virtual one-on-one meeting with BTH Capital and Pkeday Investments on 5th Oct'26, arranged at short notice. This will be followed by a physical one-on-one meeting with Anand Rathi on 6th Oct'26. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed during these interactions.
Intimation of Schedule of Analyst/Institutional Investor Meet.
Intimation · 29 Sept 2026, 12:35 am
Capillary Technologies Schedules One-on-One Analyst Meeting Capillary Technologies India Limited has scheduled a one-on-one Analyst meet to be conducted virtually on 1st Oct'26, pursuant to Regulation 30 of SEBI Listing Regulations. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed during the interaction, and the schedule remains subject to changes based on participant or company exigencies.
Clarification on Price Movement
Others (Uncategorized) · 26 Sept 2026, 2:43 am
Capillary Technologies Clarifies Recent Share Price Movement is Purely Market-Driven Capillary Technologies India clarified to BSE on 25th Sep'26 that recent significant movements in its share price are purely market-driven, confirming no management involvement. The company reiterated full compliance with SEBI LODR Regulation 30, confirming all operational, performance-related, and price-sensitive disclosures were made within stipulated timelines. Additionally, management stated that no undisclosed material information or events exist that could impact share price or trading volume behavior, and committed to timely future disclosures as required.
The Exchange has sought clarification from Capillary Technologies India Ltd on September 25, 2026 with reference to significant movement in price, in order to ensure that investors have ....
Others (Uncategorized) · 26 Sept 2026, 12:17 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
Acquisition/ Disposal of Shares · 22 Sept 2026, 4:48 pm
Mirae Asset Mutual Fund Trims Stake in Capillary Technologies Mirae Asset Mutual Fund sold 53,335 equity shares, representing 0.07% of the total share capital (0.06% of diluted capital), of Capillary Technologies India Ltd. via an open market transaction on 18th Sep'26. Prior to the transaction, the fund held 53,380 shares (0.07% stake). Following the sale, its residual holding stands at 45 shares, effectively reducing its equity stake in the company to 0.00%.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
Acquisition/ Disposal of Shares · 22 Sept 2026, 4:42 pm
Mirae Asset Mutual Fund Trims Stake in Capillary Technologies India Mirae Asset Mutual Fund sold 53,335 equity shares (0.07% of total voting capital / 0.06% of diluted capital) of Capillary Technologies India Ltd. via an open market transaction on 18th Sep'26. Prior to the sale, the fund held 53,380 shares (0.07% voting / 0.06% diluted capital). Following this divestment, Mirae Asset's holding stands reduced to 45 shares, effectively cutting its voting stake to 0.00%. The company’s total equity capital remains at 79,471,983 shares, with diluted share capital at 82,374,238 shares.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
Acquisition/ Disposal of Shares · 16 Sept 2026, 10:10 pm
Mirae Asset Mutual Fund Trims Stake in Capillary Technologies India Mirae Asset Mutual Fund sold 1,75,842 equity shares (0.22% of total share capital / 0.21% of diluted share capital) of Capillary Technologies India Ltd. via open market sale on 15th Sep'26. Following the transaction, the fund's holding decreased from 12,08,205 shares (1.52% total capital / 1.47% diluted) to 10,32,363 shares, representing 1.30% of total voting share capital and 1.25% of diluted share capital.